H01 Entering Patients Into Cancer Clinical Trials (AM) + Cancer Treatments & Their Side Effects (PM)Info Location Attendee Categories Contact More Info Event Information![]()
DescriptionEntering patients into cancer clinical trials (10:00 – 13:00) Cancer Treatments and their side effects (14:00 – 17:00) Please see the Additional Info Tab for full details of this course. A light lunch will be provided.
Event Location![]()
Attendee Categories4) Attendees From For-Profit Organisations
Additional ItemsContactFor all queries in regards to this Course please contact the following :- Giulia Pellizzari PLEASE ONLY CONTACT THE ONLINE STORE DIRECTLY IF YOU ARE EXPERIENCING PROBLEMS WITH YOUR DEBIT/CREDIT CARD PAYMENT, FOR ALL OTHER QUERIES RELATING TO THIS COURSE, INCLUDING CANCELLATIONS THESE SHOULD BE DIRECTED TO THE CONTACT DETAILS ABOVE. More InformationEntering patients into cancer clinical trials (10:00 – 13:00): This session gives a comprehensive overview of the clinical pathways cancer patients can take to be eventually referred for trial entry. The first part of the session spans across the diagnostic methods and staging of cancer and gives a brief overview of the common tests carried out prior to trial treatment. In the second part of the session participants will learn about the importance of ensuring only eligible patients enter a trial and how eligibility criteria help to safeguard patients and differ amongst different phases of trials. They will also learn the importance of assessing treatment compliance and how every clinical intervention comes with a different set of challenges in collecting data about patient compliance. Cancer Treatments and their side effects (14:00 – 17:00): This session is a basic introduction to cancer treatments and their most common side effects and adverse reactions. The course provides an overview on cancer surgery, radiotherapy and chemotherapy as well as insights on the mechanisms of action of targeted therapies such as monoclonal antibodies, small inhibitory molecules, CAR-T cell therapy and immune checkpoint inhibitors. Participants will also learn about the mechanisms of toxicity linked to the different categories of cancer therapy and how these are managed. Fees are based on the attendee's organisation as follows: £0 free for attendees from the Cancer Institute £25 for attendees from units within the Institute of Clinical Trials and Methodology (ICTM) which are:
£25 for attendees from non-profit organisations £50 for attendees from for-profit organisations *The free places require a password to book; please email ctc.training@ucl.ac.uk to request this. Emails must be sent from your UCL account and include your name, job title, and the department which you are working in. A cancellation fee of £40 will be charged to your department for late cancellations (less than 14 days) and no-shows for all courses. Other UCL attendees who are required to pay the course fee can do this by reserving a free place on the online store and then paying by IDT, please email ctc.training@ucl.ac.uk who can assist you with this* | ||||||||||||||||




